Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Leo Pharma invests USD 0.5m in Microbiome technology
April 13, 2018

The medical company Leo Pharma invests USD 0.5m in the American company Naked Biome, which develops treatments for skin diseases. As part of the agreement, Leo Pharma will be part of the Naked Biome Advisory Board focusing on counseling in clinical plans and formulation development, according to the press release.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: